Reverse Transcribing RNA Viruses

CCHEMISTRY METALLURGY C12Biochemistry C12NMICRO-ORGANISMS OR ENZYMES COMPOSITIONS THEREOF PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS MUTATION OR GENETIC ENGINEERING CULTURE MEDIA

C12N2740/00Reverse Transcribing RNA Viruses

C12N2740/00011Reverse Transcribing RNA Viruses C12N2740/00021Viruses as such C12N2740/00022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes C12N2740/00023Virus like particles [VLP] C12N2740/00031Uses of virus other than therapeutic or vaccine C12N2740/00032Use of virus as therapeutic agent, other than vaccine C12N2740/00033Use of viral protein as therapeutic agent other than vaccine C12N2740/00034Use of virus or viral component as vaccine C12N2740/00041Use of virus, viral particle or viral elements as a vector C12N2740/00042virus or viral particle as vehicle C12N2740/00043viral genome or elements thereof as genetic vector C12N2740/00044Chimeric viral vector comprising heterologous viral elements for production of another viral vector C12N2740/00045Special targeting system for viral vectors C12N2740/00051Methods of production or purification of viral material C12N2740/00052relating to complementing cells and packaging systems for producing virus or viral particles C12N2740/00061Methods of inactivation or attenuation C12N2740/00062by genetic engineering C12N2740/00063by chemical treatment C12N2740/00064by serial passage C12N2740/00071Demonstrated in vivo effect C12N2740/00088For redistribution C12N2740/10011Retroviridae C12N2740/10021Viruses as such C12N2740/10022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes C12N2740/10023Virus like particles [VLP] C12N2740/10031Uses of virus other than therapeutic or vaccine C12N2740/10032Use of virus as therapeutic agent, other than vaccine C12N2740/10033Use of viral protein as therapeutic agent other than vaccine C12N2740/10034Use of virus or viral component as vaccine C12N2740/10041Use of virus, viral particle or viral elements as a vector C12N2740/10042virus or viral particle as vehicle C12N2740/10043viral genome or elements thereof as genetic vector C12N2740/10044Chimeric viral vector comprising heterologous viral elements for production of another viral vector C12N2740/10045Special targeting system for viral vectors C12N2740/10051Methods of production or purification of viral material C12N2740/10052relating to complementing cells and packaging systems for producing virus or viral particles C12N2740/10061Methods of inactivation or attenuation C12N2740/10062by genetic engineering C12N2740/10063by chemical treatment C12N2740/10064by serial passage C12N2740/10071Demonstrated in vivo effect C12N2740/10088For redistribution C12N2740/11011Alpharetrovirus C12N2740/11021Viruses as such C12N2740/11022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes C12N2740/11023Virus like particles [VLP] C12N2740/11031Uses of virus other than therapeutic or vaccine C12N2740/11032Use of virus as therapeutic agent, other than vaccine C12N2740/11033Use of viral protein as therapeutic agent other than vaccine C12N2740/11034Use of virus or viral component as vaccine C12N2740/11041Use of virus, viral particle or viral elements as a vector C12N2740/11042virus or viral particle as vehicle C12N2740/11043viral genome or elements thereof as genetic vector C12N2740/11044Chimeric viral vector comprising heterologous viral elements for production of another viral vector C12N2740/11045Special targeting system for viral vectors C12N2740/11051Methods of production or purification of viral material C12N2740/11052relating to complementing cells and packaging systems for producing virus or viral particles C12N2740/11061Methods of inactivation or attenuation C12N2740/11062by genetic engineering C12N2740/11063by chemical treatment C12N2740/11064by serial passage C12N2740/11071Demonstrated in vivo effect C12N2740/11088For redistribution C12N2740/12011Betaretrovirus C12N2740/12021Viruses as such C12N2740/12022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes C12N2740/12023Virus like particles [VLP] C12N2740/12031Uses of virus other than therapeutic or vaccine C12N2740/12032Use of virus as therapeutic agent, other than vaccine C12N2740/12033Use of viral protein as therapeutic agent other than vaccine C12N2740/12034Use of virus or viral component as vaccine C12N2740/12041Use of virus, viral particle or viral elements as a vector C12N2740/12042virus or viral particle as vehicle C12N2740/12043viral genome or elements thereof as genetic vector C12N2740/12044Chimeric viral vector comprising heterologous viral elements for production of another viral vector C12N2740/12045Special targeting system for viral vectors C12N2740/12051Methods of production or purification of viral material C12N2740/12052relating to complementing cells and packaging systems for producing virus or viral particles C12N2740/12061Methods of inactivation or attenuation C12N2740/12062by genetic engineering C12N2740/12063by chemical treatment C12N2740/12064by serial passage C12N2740/12071Demonstrated in vivo effect C12N2740/12088For redistribution C12N2740/13011Gammaretrovirus C12N2740/13021Viruses as such C12N2740/13022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes C12N2740/13023Virus like particles [VLP] C12N2740/13031Uses of virus other than therapeutic or vaccine C12N2740/13032Use of virus as therapeutic agent, other than vaccine C12N2740/13033Use of viral protein as therapeutic agent other than vaccine C12N2740/13034Use of virus or viral component as vaccine C12N2740/13041Use of virus, viral particle or viral elements as a vector C12N2740/13042virus or viral particle as vehicle C12N2740/13043viral genome or elements thereof as genetic vector C12N2740/13044Chimeric viral vector comprising heterologous viral elements for production of another viral vector C12N2740/13045Special targeting system for viral vectors C12N2740/13051Methods of production or purification of viral material C12N2740/13052relating to complementing cells and packaging systems for producing virus or viral particles C12N2740/13061Methods of inactivation or attenuation C12N2740/13062by genetic engineering C12N2740/13063by chemical treatment C12N2740/13064by serial passage C12N2740/13071Demonstrated in vivo effect C12N2740/13088For redistribution C12N2740/14011Deltaretrovirus C12N2740/14021Viruses as such C12N2740/14022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes C12N2740/14023Virus like particles [VLP] C12N2740/14031Uses of virus other than therapeutic or vaccine C12N2740/14032Use of virus as therapeutic agent, other than vaccine C12N2740/14033Use of viral protein as therapeutic agent other than vaccine C12N2740/14034Use of virus or viral component as vaccine C12N2740/14041Use of virus, viral particle or viral elements as a vector C12N2740/14042virus or viral particle as vehicle C12N2740/14043viral genome or elements thereof as genetic vector C12N2740/14044Chimeric viral vector comprising heterologous viral elements for production of another viral vector C12N2740/14045Special targeting system for viral vectors C12N2740/14051Methods of production or purification of viral material C12N2740/14052relating to complementing cells and packaging systems for producing virus or viral particles C12N2740/14061Methods of inactivation or attenuation C12N2740/14062by genetic engineering C12N2740/14063by chemical treatment C12N2740/14064by serial passage C12N2740/14071Demonstrated in vivo effect C12N2740/14088For redistribution C12N2740/15011Lentivirus, not HIV C12N2740/15021Viruses as such C12N2740/15022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes C12N2740/15023Virus like particles [VLP] C12N2740/15031Uses of virus other than therapeutic or vaccine C12N2740/15032Use of virus as therapeutic agent, other than vaccine C12N2740/15033Use of viral protein as therapeutic agent other than vaccine C12N2740/15034Use of virus or viral component as vaccine C12N2740/15041Use of virus, viral particle or viral elements as a vector C12N2740/15042virus or viral particle as vehicle C12N2740/15043viral genome or elements thereof as genetic vector C12N2740/15044Chimeric viral vector comprising heterologous viral elements for production of another viral vector C12N2740/15045Special targeting system for viral vectors C12N2740/15051Methods of production or purification of viral material C12N2740/15052relating to complementing cells and packaging systems for producing virus or viral particles C12N2740/15061Methods of inactivation or attenuation C12N2740/15062by genetic engineering C12N2740/15063by chemical treatment C12N2740/15064by serial passage C12N2740/15071Demonstrated in vivo effect C12N2740/15088For redistribution C12N2740/16011Human Immunodeficiency Virus, HIV C12N2740/16021Viruses as such C12N2740/16022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes C12N2740/16023Virus like particles [VLP] C12N2740/16031Uses of virus other than therapeutic or vaccine C12N2740/16032Use of virus as therapeutic agent, other than vaccine C12N2740/16033Use of viral protein as therapeutic agent other than vaccine C12N2740/16034Use of virus or viral component as vaccine C12N2740/16041Use of virus, viral particle or viral elements as a vector C12N2740/16042virus or viral particle as vehicle C12N2740/16043viral genome or elements thereof as genetic vector C12N2740/16044Chimeric viral vector comprising heterologous viral elements for production of another viral vector C12N2740/16045Special targeting system for viral vectors C12N2740/16051Methods of production or purification of viral material C12N2740/16052relating to complementing cells and packaging systems for producing virus or viral particles C12N2740/16061Methods of inactivation or attenuation C12N2740/16062by genetic engineering C12N2740/16063by chemical treatment C12N2740/16064by serial passage C12N2740/16071Demonstrated in vivo effect C12N2740/16088For redistribution C12N2740/16111concerning HIV env C12N2740/16122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes C12N2740/16134Use of virus or viral component as vaccine C12N2740/16171Demonstrated in vivo effect C12N2740/16188For redistribution C12N2740/16211concerning HIV gagpol C12N2740/16222New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes C12N2740/16234Use of virus or viral component as vaccine C12N2740/16271Demonstrated in vivo effect C12N2740/16288For redistribution C12N2740/16311concerning HIV regulatory proteins C12N2740/16322New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes C12N2740/16334Use of virus or viral component as vaccine C12N2740/16371Demonstrated in vivo effect C12N2740/16388For redistribution C12N2740/17011Spumavirus C12N2740/17021Viruses as such C12N2740/17022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes C12N2740/17023Virus like particles [VLP] C12N2740/17031Uses of virus other than therapeutic or vaccine C12N2740/17032Use of virus as therapeutic agent, other than vaccine C12N2740/17033Use of viral protein as therapeutic agent other than vaccine C12N2740/17034Use of virus or viral component as vaccine C12N2740/17041Use of virus, viral particle or viral elements as a vector C12N2740/17042virus or viral particle as vehicle C12N2740/17043viral genome or elements thereof as genetic vector C12N2740/17044Chimeric viral vector comprising heterologous viral elements for production of another viral vector C12N2740/17045Special targeting system for viral vectors C12N2740/17051Methods of production or purification of viral material C12N2740/17052relating to complementing cells and packaging systems for producing virus or viral particles C12N2740/17061Methods of inactivation or attenuation C12N2740/17062by genetic engineering C12N2740/17063by chemical treatment C12N2740/17064by serial passage C12N2740/17071Demonstrated in vivo effect C12N2740/17088For redistribution